J1944 Aripiprazole Lauroxil HCPCS Reimbursement

HCPCS Level II code J1944 denotes the per-milligram billing unit for injection of aripiprazole lauroxil (Aristada), a long-acting injectable antipsychotic used in the treatment of schizophrenia and related disorders. As a drug administration code tied to a branded long-acting formulation, J1944 is important for medication utilization tracking, payer coverage determinations, and outpatient behavioral health service billing across the U.S.

Key national payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of service context and site-of-service implications, typical billing and coding considerations tied to per-milligram HCPCS reporting, and what to expect in payer coverage workflows for long-acting injectable antipsychotics.

This summary provides clinicians, billing professionals, and policy analysts with benchmarks for clinical context and utilization, an outline of common payer approaches to coverage and precertification, and pointers to policy updates affecting specialty drug billing in outpatient settings. Data not available in the input is noted where applicable.

Billing Code Overview

HCPCS Level II code J1944 describes an injection of aripiprazole lauroxil (Aristada), 1 mg. This code represents a medication administration service for a long-acting injectable antipsychotic formulation of aripiprazole delivered in measured milligram units.

Service type: Medication injection / drug administration

Typical site of service: Outpatient clinic, behavioral health clinic, or physician office where long-acting injectable antipsychotic therapy is administered

Clinical Context

A 28-year-old patient with a documented diagnosis of schizophrenia spectrum disorder presents for a scheduled long-acting antipsychotic injection. The clinician documents ongoing partial adherence to oral antipsychotics and a history of relapse when doses were missed. The patient receives J1944 (aripiprazole lauroxil, 1 mg units billed in milligrams) administered intramuscularly in the clinic's outpatient behavioral health infusion suite. The clinical workflow includes: pre-injection assessment of vitals and mental status, verification of the ordered dose and lot numbers, informed consent and review of prior adverse reactions, preparation and administration of the intramuscular injection by a registered nurse or advanced practice clinician, 15–30 minutes post-injection observation for immediate adverse effects, documentation of medication lot/expiration and injection site, and scheduling the next dose per the treatment regimen. Typical sites of service are outpatient psychiatric clinics, behavioral health infusion centers, or ambulatory care clinics that provide long-acting injectable antipsychotic therapy. The typical patient scenario involves routine maintenance dosing for schizophrenia or schizoaffective disorder to improve adherence and reduce relapse risk.

Coding Specifications

Modifier	Description	When to Use
`00`	Default/No modifier	When no special circumstances apply and no other modifier is appropriate

Taxonomy Code	Specialty	Notes
`2084P0800X`	Psychiatrist	Psychiatrists commonly prescribe and oversee long-acting injectable antipsychotic therapy
`363L00000X`	Registered Nurse	Registered nurses typically prepare and administer intramuscular long-acting injections
`1835P0800X`	Nurse Practitioner	Nurse practitioners frequently manage outpatient psychiatric medication clinics and administer injections
`163W00000X`	Physician Assistant	Physician assistants often provide medication administration and follow-up in outpatient settings
`207Q00000X`	Clinical Pharmacist	Clinical pharmacists may manage medication monitoring, dosing schedules, and patient education

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`F20.9`	Schizophrenia, unspecified	Primary indication for long-acting antipsychotic therapy such as aripiprazole lauroxil
`F25.0`	Schizoaffective disorder, bipolar type	Long-acting injectable antipsychotics are used for maintenance treatment in schizoaffective disorder
`F25.1`	Schizoaffective disorder, depressive type	Relevant for patients requiring sustained antipsychotic coverage to prevent relapse
`F20.5`	Residual schizophrenia	Maintenance therapy with long-acting formulations may be indicated to manage residual symptoms and prevent exacerbation
`F20.0`	Paranoid schizophrenia	A common schizophrenia subtype treated with long-acting injectable antipsychotics
`F32.9`	Major depressive disorder, single episode, unspecified	Included when comorbid mood disorders are present and antipsychotic adjunctive therapy is considered
`Z79.899`	Other long term (current) drug therapy	Used to document ongoing long-term antipsychotic therapy in the patient's problem list

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`96372`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular	Commonly used to bill administration of a single intramuscular medication when separate administration coding is required alongside the J-code
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes	Commonly billed for the clinical visit when evaluating and documenting the patient prior to injection
`96361`	Intravenous infusion, therapeutic, prophylactic, or diagnostic; initial 1 hour (for infusion services)	Not typically used for IM injections but relevant if patient receives concurrent IV therapies in an infusion center
`99070`	Supplies and materials (except spectacles), provided by the physician over and above those usually included with the office visit or procedure	Used when additional supplies (e.g., specialized syringes, monitoring supplies) are required for administration
`96127`	Brief emotional/behavioral assessment (e.g., depression inventory)	Used when brief validated symptom monitoring is performed at visit to track response to antipsychotic therapy

OpenPayer

Summary & Overview

HCPCS Level II J1944: Injection, aripiprazole lauroxil (Aristada), 1 mg